Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis
- PMID: 12859958
- DOI: 10.1016/s0006-291x(03)01204-x
Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis
Abstract
Prostaglandins are a family of structurally related molecules formed by many cells in response to extrinsic stimuli. A member of this family, 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)), shows unique biological properties including anti-inflammatory, anti-viral, and anti-tumour activity, and has attracted much attention as a high affinity ligand for the peroxisome proliferator-activated receptor gamma. Increasing evidence points to additional effects. We investigated several structurally related prostaglandins in comparison to 15d-PGJ(2) with respect to their apoptosis-inducing capacity in human umbilical endothelial cells (HUVEC). Cell viability was tested with a modified MTT assay and apoptosis was detected by Annexin V staining and cell cycle analysis by flow cytometry. Incubation of confluent HUVECs with 15d-PGJ(2) markedly reduced endothelial cell viability which was due to apoptosis. In contrast, none of the other PGs tested affected cell viability. Interestingly, the cyclopentenone ring alone dose-dependently reduced cell viability and significantly induced apoptosis in HUVECs with as low a concentration as 0.25 microM. In conclusion, we report that the cyclopentenone moiety of cyPGs is an essential component for the apoptosis-inducing properties of 15d-PGJ(2). For 15d-PGJ(2) the position of the cyclopentenone ring in conjunction with the side chains yields a molecule with unique biological properties.
Similar articles
-
The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.Biochem Pharmacol. 2004 Apr 1;67(7):1259-67. doi: 10.1016/j.bcp.2003.10.037. Biochem Pharmacol. 2004. PMID: 15013841
-
Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.J Immunol. 2003 Nov 15;171(10):5148-56. doi: 10.4049/jimmunol.171.10.5148. J Immunol. 2003. PMID: 14607914
-
The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.J Immunol. 2003 May 1;170(9):4578-92. doi: 10.4049/jimmunol.170.9.4578. J Immunol. 2003. PMID: 12707336
-
Cyclopentenone prostaglandins: new insights on biological activities and cellular targets.Med Res Rev. 2001 May;21(3):185-210. doi: 10.1002/med.1006. Med Res Rev. 2001. PMID: 11301410 Review.
-
Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.Int Arch Allergy Immunol. 2007;143 Suppl 1:15-22. doi: 10.1159/000101399. Epub 2007 May 1. Int Arch Allergy Immunol. 2007. PMID: 17541271 Review.
Cited by
-
Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.Pharm Res. 2007 Mar;24(3):566-74. doi: 10.1007/s11095-006-9175-2. Pharm Res. 2007. PMID: 17245650 Free PMC article.
-
Laminar flow activation of ERK5 leads to cytoprotective effect via CHIP-mediated p53 ubiquitination in endothelial cells.Anat Cell Biol. 2011 Dec;44(4):265-73. doi: 10.5115/acb.2011.44.4.265. Epub 2011 Dec 30. Anat Cell Biol. 2011. PMID: 22254155 Free PMC article.
-
15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53.J Biol Chem. 2008 Oct 31;283(44):30273-88. doi: 10.1074/jbc.M804196200. Epub 2008 Aug 21. J Biol Chem. 2008. PMID: 18718914 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources